Maternal Vitamin D Levels During Pregnancy and Offspring Autism Spectrum Disorder

• Published in: Biological psychiatry (1969) 2021-12, Vol.90 (11), p.790-797
• Main Authors: Sourander, Andre, Upadhyaya, Subina, Surcel, Heljä-Marja, Hinkka-Yli-Salomäki, Susanna, Cheslack-Postava, Keely, Silwal, Sanju, Sucksdorff, Minna, McKeague, Ian W., Brown, Alan S.
• Format: Article
• Language: English
• Subjects: ASD; Autism spectrum disorder; Autism Spectrum Disorder - epidemiology; Autism Spectrum Disorder - etiology; Case-Control Studies; Cohort Studies; Female; Humans; Maternal sera 25(OH)D; Maternal vitamin D; Mothers; Pregnancy; Prenatal; Vitamin D
• ISSN: 0006-3223; 1873-2402
• DOI: 10.1016/j.biopsych.2021.07.012

Findings from previous studies on maternal 25-hydroxyvitamin D [25(OH)D] levels during pregnancy and autism spectrum disorder (ASD) in offspring are inconsistent. The association between maternal 25(OH)D levels during pregnancy and offspring ASD was examined using data from a nationwide population-based register with a nested case-control study design. The ASD cases (n = 1558) were born between 1987 and 2004 and received a diagnosis of ASD by 2015; cases were matched with an equal number of controls. Maternal 25(OH)D levels during pregnancy were measured using quantitative immunoassay from maternal sera collected during the first and early second trimesters and archived in the national biobank of the Finnish Maternity Cohort. Conditional logistic regression examined the association between maternal 25(OH)D levels and offspring ASD. In the adjusted model, there was a significant association between increasing log-transformed maternal 25(OH)D levels and decreasing risk of offspring ASD (adjusted odds ratio [aOR] 0.75, 95% confidence interval [CI] 0.62–0.92, p = .005). Analyses by quintiles of maternal 25(OH)D levels revealed increased odds for ASD in the 2 lowest quintiles,